2-(Chloromethyl)-3-methoxypyridine → HCID 66706914, compound
Reaction equation
C(OC([N:8]1[CH2:14][CH2:13][C:12]2[C:15]([S:20][C:21](=O)N(C)C)=[C:16]([Cl:19])[CH:17]=[CH:18][C:11]=2[CH2:10][CH2:9]1)=O)(C)(C)C.ClC[C:28]1[C:33]([O:34][CH3:35])=[CH:32][CH:31]=[CH:30][N:29]=1>>[ClH:19].[Cl:19][C:16]1[CH:17]=[CH:18][C:11]2[CH2:10][CH2:9][NH:8][CH2:14][CH2:13][C:12]=2[C:15]=1[S:20][CH2:21][C:28]1[C:33]([O:34][CH3:35])=[CH:32][CH:31]=[CH:30][N:29]=1Participants
3
Procedure
Use a method similar to the Example 315, using 3-tert-butoxycarbonyl-7-chloro-6-dimethylcarbamoylthio-2,3,4,5-tetrahydro-1H-benzo[d]azepine and 2-chloromethyl-3-methoxypyridine to give, after deprotection by a method similar to the General Procedure 1-4, the title compound as a white solid (71 mg). MS (APCI+) m/z: 335 (M+H)+.
Workup
- customto give
Sources & evidence
- ORD record
- ord-61c89aca070d422bbec9f20c338a5f99
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08022062B2
Reaction notes
Loading…